Effect of obesity intervention programs on adipokines, insulin resistance, lipid profile, and low-grade inflammation in 3-to 5-y-old children

Pediatric Research

Volumn 75, Issue 2, 2014, Pages 352-357

  Bocca, Gianni ^a   Corpeleijn, Eva ^b   Stolk, Ronald P ^b   Wolffenbuttel, Bruce H ^b   Sauer, Pieter J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOKINES; ADIPOSE TISSUE; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; CHILD, PRESCHOOL; FEMALE; GLUCOSE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; OVERWEIGHT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SUBCUTANEOUS FAT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHILD HEALTH CARE; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE MARKER; EATING HABIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROUP THERAPY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PARENT COUNSELING; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84894192610     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.216     Document Type: Article

References (26)

1. Sch?beck Y, Talma H, van Dommelen P, et al. Increase in prevalence of overweight in Dutch children and adolescents: a comparison of nationwide growth studies in 1980, 1997 and 2009. PLoS ONE 2011;6:e27608.
2. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet 2002;360:473-82.
3. Zimmet P, Alberti KG, Kaufman F, et al.; IDF Consensus Group. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes 2007;8:299-306.
4. Martos R, Valle M, Morales RM, Ca?te R, Gasc? F, Urbano MM. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction markers in obese prepubertal children after 9 months of body mass index SD score loss. Metabolism 2009;58:1153-60.
5. Roth CL, Reinehr T. Roles of gastrointestinal and adipose tissue peptides in childhood obesity and changes after weight loss due to lifestyle intervention. Arch Pediatr Adolesc Med 2010;164:131-8.
6. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-3.
7. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W. High-sensitive C-reactive protein, tumor necrosis factor ?, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 2005;54:1155-61.
8. Roth CL, Kratz M, Ralston MM, Reinehr T. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metab Clin Exp 2011;60:445-52.
9. Oude Luttikhuis H, Baur L, Jansen H, et al. Interventions for treating obesity in children. Cochrane Database Syst Rev 2009;CD001872.
10. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-4.
11. Bocca G, Corpeleijn E, Stolk RP, Sauer PJ. Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children: a randomized controlled clinical trial. Arch Pediatr Adolesc Med 2012;166:1109-15.
12. Reinehr T, de Sousa G, Andler W. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obes Res 2005;13:1824-33.
13. Ford AL, Hunt LP, Cooper A, Shield JP. What reduction in BMI SDS is required in obese adolescents to improve body composition and cardiometabolic health? Arch Dis Child 2010;95:256-61.
14. van der Heijden GJ, Wang ZJ, Chu ZD, et al. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 2010;18:384-90.
15. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6.
16. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120:Suppl 4:S164-92.
17. Hardy OT, Wiecha J, Kim A, et al. Effects of a multicomponent wellness intervention on dyslipidemia among overweight adolescents. J Pediatr Endocrinol Metab 2012;25:79-82.
18. Taubes G. Insulin resistance. Prosperity's plague. Science 2009;325:256-60.
19. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2276-83.
20. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med 2005;5:333-9.
21. Weiss R, Kaufman FR. Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 2008;31:Suppl 2:S310-6.
22. Corpeleijn E, Saris WH, Blaak EE. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Obes Rev 2009;10:178-93.
23. Pecoraro P, Guida B, Caroli M, et al. Body mass index and skinfold thickness versus bioimpedance analysis: fat mass prediction in children. Acta Diabetol 2003;40:Suppl 1:S278-81.
24. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE. Validity and reproducibility of ultrasonography for the measurement of intraabdominal adipose tissue. Int J Obes Relat Metab Disord 2001;25:1346-51.
25. Liem ET, De Lucia Rolfe E, L'Ab? C, Sauer PJ, Ong KK, Stolk RP. Measuring abdominal adiposity in 6 to 7-year-old children. Eur J Clin Nutr 2009;63:835-41.
26. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.